HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.

Abstract
Previous papers in this series have shown that plain toxoids induced early primary antitoxin levels in women in New Guinea that were not significantly different from those induced by adsorbed toxoids but that at the end of 1 year the antitoxin levels differed significantly. Protective levels (not less than 0.01 unit/ml) induced by adsorbed toxoids persisted for more than 3 years. Results of laboratory assays of the toxoids reported in this paper show that per total human immunizing dose, the plain toxoids had 72 or less international units (IU) whereas the adsorbed toxoids had approximately 200 IU. The international "unitage" of these toxoids reflected the persistence of the human protective antitoxin level but not the early primary response. The assay results were in agreement with findings of other workers that the mouse as well as the guinea-pig may be satisfactory for potency assay of adsorbed toxoids. The need for determination of the international unitage of tetanus toxoids used in human studies and the confirmation of relationship of this value to persistence of antitoxin levels is emphasized.
AuthorsM Pittman, R W Kolb, M F Barile, M C Hardegree, E B Seligmann Jr, R Maclennan, F D Schofield
JournalBulletin of the World Health Organization (Bull World Health Organ) Vol. 43 Issue 3 Pg. 469-78 ( 1970) ISSN: 0042-9686 [Print] Switzerland
PMID5313001 (Publication Type: Journal Article)
Chemical References
  • Antibodies
  • Tetanus Toxoid
Topics
  • Animals
  • Antibodies (analysis)
  • Biological Assay
  • Female
  • Guinea Pigs
  • Humans
  • Immunization
  • Infant, Newborn
  • Infant, Newborn, Diseases (prevention & control)
  • New Guinea
  • Pregnancy
  • Tetanus (immunology, prevention & control)
  • Tetanus Toxoid (standards, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: